BUZUD and Tan Tock Seng Hospital Introduce AI-Powered Diabetes Management Solution

BUZUD, in collaboration with Tan Tock Seng Hospital (TTSH), has successfully introduced an innovative AI-powered mobile application paired with a wearable Continuous Glucose Monitoring (CGM) device. The solution, named CARB-CGM, was unveiled during a launch event on 26 February, marking a significant step forward in simplifying diabetes management and empowering patients to take control of their health.

With diabetes projected to affect up to 1 million people in Singapore by 2050, this collaboration addresses the growing need for innovative tools to help patients manage their condition with greater confidence and convenience.

Streamlining Diabetes Management with CARB-CGM

The CARB-CGM system integrates advanced AI technology with real-time glucose monitoring to simplify the complexities of diabetes care. It allows patients to make more precise insulin dosage decisions, reducing the risks of hyperglycaemia and hypoglycaemia.

Key features of the CARB-CGM system include:

• Real-Time Glucose Monitoring: The BUZUD CGM device provides minute-by-minute glucose readings via a wearable sensor, enabling patients to track their glucose levels continuously.
• AI-Powered Dietary Analysis: Patients can snap a photo of their meal, and the app will identify the food and estimate its carbohydrate content, allowing for more accurate insulin dosing.
• Insulin Sensitivity Factor Calculation: Developed in collaboration with TTSH, this feature ensures personalised insulin dosage recommendations based on individual health data.

Adjunct Associate Professor Daniel Chew, Division Chairman (Medicine) at TTSH, said, “For some patients, managing diabetes means making numerous micro-decisions every day. It is critical that we empower our patients and their caregivers to navigate complexities and be confident in their care regimes. An enhanced CARB-CGM solution can take out the guesswork on insulin administration. Empowering them with the right tools to manage their health safely—both at home and at work—can help reduce anxiety and avoid unnecessary hospital visits.”

Empowering Patients and Enhancing Care

The CARB-CGM system is designed to address the challenges faced by patients who require multiple daily insulin doses. Insulin dosage depends on various factors, including health condition, lifestyle, daily routines, and food intake, which can vary significantly. Miscalculations in insulin dosage can lead to serious complications, such as hyperglycaemia or hypoglycaemia, which may hinder patients’ progress and confidence.

“This collaboration with TTSH marks a pivotal moment in patient care,” said Frankie Fan, CEO of BUZUD. “The solution delivers enhanced patient outcomes through better glycaemic control and personalised support. Data-driven insights enable healthcare teams to optimise treatment decisions and improve long-term care management. We’re REimagining diabetes management through AI technology, focusing on reducing complications and improving quality of life. This aligns with our mission to leverage technology for superior healthcare outcomes.”

Leveraging Expertise to Accelerate AI Adoption

The partnership between TTSH and BUZUD, facilitated by the National Healthcare Group’s (NHG) Centre for Medical Technologies and Innovations (CMTi), highlights the importance of collaboration between public and private sectors to address unmet healthcare needs.

Adjunct Associate Professor Daniel Chew added, “Digital technologies have made significant strides in diagnostics and treatment. This partnership leverages TTSH’s strong culture of innovation and showcases the transformative potential of AI technologies to enhance patient care and empowerment.”

The partnership was formalised with the signing of a Research Collaboration Agreement (RCA) between Mr Christopher Soh, Deputy Director of Nursing at TTSH, and Mr Frankie Fan, CEO of BUZUD.

Next Steps

Following the introduction of the CARB-CGM system, the next phase of the partnership will involve a validation study to assess its accuracy and effectiveness, with potential refinements to further enhance its capabilities. This will be followed by a pilot adoption phase with a small group of patients before expanding to include more patients in subsequent stages.

https://buzud.com/2025/03/01/buzud-and-tan-tock-seng-hospital-introduce-ai-powered-diabetes-management-solution/